Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.54 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.40 |
| ▸ | ABAT | P80404 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3480423 | 0.93 | ESR1 (0.62) | ESR1ESR2THRATHRBNPC1 | |
| SCHEMBL1121520 | 0.89 | ESR1 (0.62) | ESR1ESR2THRATHRBNPC1 | |
| SCHEMBL10717284 | 0.84 | ESR1 (0.46) | ESR1ESR2THRATHRBNPC1 | |
| SCHEMBL24759726 | 0.81 | ESR1 (0.52) | ESR1ESR2THRATHRBNPC1 | |
| SCHEMBL27554304 | 0.80 | ESR1 (0.53) | ESR1ESR2THRATHRBNPC1 | |
| Butane SCHEMBL27554305 | 0.78 | CNR2 (0.44) | IDH1 | |
| SCHEMBL28498365 | 0.76 | ESR1 (0.46) | ESR1ESR2THRATHRBNPC1 | |
| SCHEMBL2788843 | 0.76 | ESR1 (0.46) | ESR1ESR2THRATHRBNPC1 | |
| SCHEMBL68926 | 0.75 | FASN (0.35) | CA2 | |
| SCHEMBL278380 | 0.75 | THRA (0.48) | ESR1ESR2THRATHRBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630668-B2 | Liquid compression molding material | NAMICS CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20250026920-A1 | LIQUID EPOXY RESIN COMPOSITION FOR USE AS MOLD UNDERFILL MATERIAL FOR TSV | SK Hynix Inc. (KR) | 2025-01-23 | — | — | US | disclosed |
| US-11760870-B2 | Resin composition for encapsulation | NAGASE CHEMTEX CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| US-20230203236-A1 | LIQUID COMPRESSION MOLDING MATERIAL | NAMICS CORPORATION (JP) | 2023-06-29 | — | — | US | disclosed |
| CN-115668484-A | Liquid compression molding material | 纳美仕有限公司 | 2023-01-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630668-B2 | Liquid compression molding material | PIEZO1, TSNAX, TMCO1 | ESR1 1967/4885ESR2 3153/4885THRA 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.